ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-GFAP Antibody [GF-05] (A280512)

This product is discontinued

Anti-GFAP Antibody [GF-05] (A280512) has been discontinued and is no longer available.

View all GFAP Antibodies.

Name
Anti-GFAP Antibody [GF-05]
Description
Mouse anti Human GFAP
Specificity
Mouse anti Human Glial Fibrillary Acidic Protein antibody, clone GF-05 recognizes humanm glial fibrillary acidic protein (GFAP). GFAP is a 432 amino acid intermediate filament protein. Mouse anti Human Glial Fibrillary Acidic Protein antibody, clone GF-05 recognisez ~38-45 kDa neurofilaments in immunoblots. Mouse anti Human Glial Fibrillary Acidic Protein antibody, clone GF-05 is also reactive in ELISA with antigen coating at 5 μg/ml and may react with GFAP from other species.Mutations in the GFAP gene may result in presentation of Alexander disease (ALXDRD), a rare neurological condition affecting infants and characterized by myelination failure leading to early death (Brenner et al. 2001)
Applications
WB, ELISA
Reactivity
Human, Cynomolgus Monkey
Immunogen
Native GFAP purified from human brain.
Host
Mouse
Clonality
Monoclonal
Clone ID
GF-05
Isotype
IgG2b
Conjugate

Unconjugated

Purification
Protein G chromatography.
Concentration
1 mg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with < 0.1% Sodium Azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Synonyms
Glial fibrillary acidic protein
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Most popular Anti-GFAP Antibodies

Alternative products to Anti-GFAP Antibody [GF-05] (A280512)

Proteins predicted to interact with GFAP

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
95.6% Relevancy Score
93.1% Relevancy Score
92.5% Relevancy Score
91.9% Relevancy Score
91.3% Relevancy Score
88.6% Relevancy Score
88.5% Relevancy Score
88.3% Relevancy Score
87.6% Relevancy Score